Nurix Therapeutics Announces Presentation of NX-1607 Preclinical Data at AACR
CBL-B inhibitor NX-1607 mediates anti-tumor activity through both T cells and NK cellsPreclinical tumor models…
CBL-B inhibitor NX-1607 mediates anti-tumor activity through both T cells and NK cellsPreclinical tumor models…
AFM24 preclinical in vivo data will be presented as a poster Data on AFM13 in…
SAN CARLOS, Calif., March 10, 2021 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a…
Media Release Copenhagen, Denmark, March 10, 2021 ·Two posters featuring innovative Genmab bispecific antibody programs…
SEATTLE, March 10, 2021 (GLOBE NEWSWIRE) — SEngine Precision Medicine, a precision oncology company revolutionizing…
ZUG, Switzerland and CAMBRIDGE, Mass., March 10, 2021 (GLOBE NEWSWIRE) — CRISPR Therapeutics (Nasdaq: CRSP),…
— Two presentations to highlight AO-176’s potential in lymphoma and T-ALL — BRISBANE, Calif. and ST….
– Healthy volunteer clinical data for exoIL-12 accepted as a late-breaking abstract – – Preclinical data…
WATERTOWN, Mass., March 10, 2021 (GLOBE NEWSWIRE) — C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a…
CAMBRIDGE, Mass., March 10, 2021 (GLOBE NEWSWIRE) — TCR2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage…
CAMBRIDGE, Mass. and NEW YORK, March 10, 2021 (GLOBE NEWSWIRE) — Black Diamond Therapeutics, Inc….
Clinical benefit in previously unresponsive tumors, including CRC, ovarian, and endometrial Confirmed responses in cold…
CAMBRIDGE, Mass., March 10, 2021 (GLOBE NEWSWIRE) — Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company…
SAN MATEO, Calif. and CAMBRIDGE, Mass., March 10, 2021 (GLOBE NEWSWIRE) — Kronos Bio, Inc….
CAMBRIDGE, Mass., March 10, 2021 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical…
CAMBRIDGE, Mass., March 10, 2021 (GLOBE NEWSWIRE) — Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) (“Checkmate”), a…
CRANBURY, N.J., March 10, 2021 (GLOBE NEWSWIRE) — PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision…
~ Presentation to highlight the potential of Gennao’s proprietary, non-viral gene monoclonal antibody (GMAB) platform…
PALO ALTO, Calif., March 10, 2021 (GLOBE NEWSWIRE) — Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical…
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, March 10, 2021 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals,…